Quick Links

Alzheimer’s Tag

To evaluate the efficacy, safety, and tolerability of AVP-786 compared to placebo, for the treatment of agitation in patients with dementia of the Alzheimer's type To evaluate the effects of AVP-786 compared to placebo on neuropsychiatric symptoms To evaluate the effects of AVP-786 compared to placebo on...

To evaluate the clinical efficacy of ATH-1017 To determine the safety and tolerability of ATH-1017 To evaluate the clinical efficacy of ATH-1017 separately on: (1) cognition and (2) clinical global impression of change To evaluate the effect of ATH-1017 on activities of daily living To determine the plasma pharmacokinetic (PK) profile...

To assess the effect of donanemab versus placebo on clinical progression in participants with early symptomatic AD with demonstrated presence of tau pathology To assess the effect of donanemab versus placebo on clinical progression of participants with early symptomatic AD To assess the effect of donanemab versus...

SITE PARTNERS
uw-footer